Amlodipine is a calcium channel blocker (CCB) drug used to treat high blood pressure, angina, and chronic stable angina. It works by relaxing the muscles of the blood vessels, allowing them to widen and lower blood pressure. Amlodipine has been available in the United States since 1991 and is now one of the most widely prescribed drugs in the world. It is also used to treat other cardiovascular conditions, such as heart failure, coronary artery disease, and arrhythmias. As more research is conducted on amlodipine, a better understanding of its interactions with other medications and its potential benefits for cardiovascular care is being revealed.
Amlodipine has a wide range of interactions with other medications, including those used to treat hypertension, angina, and other cardiovascular conditions. It is important to understand these interactions to ensure that the medication is used safely and effectively. Amlodipine is a substrate of the cytochrome P450 (CYP) 3A4 and CYP2C8 enzymes. This means that it is metabolized by these enzymes, and drugs that inhibit or induce these enzymes can affect the metabolism of amlodipine. For example, drugs that inhibit CYP3A4, such as ketoconazole, can increase the levels of amlodipine in the blood, while drugs that induce CYP3A4, such as rifampin, can decrease the levels of amlodipine in the blood. Amlodipine can also interact with other medications, such as diuretics, ACE inhibitors, angiotensin receptor blockers (ARBs), and beta-blockers. These interactions can affect the effectiveness of the medications, as well as the side effects. For example, when taken with diuretics, amlodipine can reduce the effectiveness of the diuretic, while when taken with ACE inhibitors, it can increase the risk of side effects. Amlodipine can also interact with certain foods and herbal supplements, such as grapefruit juice, St. John’s wort, and ginseng. These interactions can affect the absorption of amlodipine, as well as its effectiveness and side effects.
A better understanding of the interactions of amlodipine can help unlock a new level of cardiovascular care. By understanding the interactions of amlodipine with other medications, foods, and herbal supplements, doctors can more effectively prescribe and monitor the use of amlodipine to ensure it is used safely and effectively. In addition, doctors can use this knowledge to better tailor treatment plans for their patients. For example, if a patient is taking a medication that inhibits CYP3A4, such as ketoconazole, the doctor can adjust the dose of amlodipine to ensure it is effective. Similarly, if a patient is taking a medication that induces CYP3A4, such as rifampin, the doctor can adjust the dose of amlodipine to reduce the risk of side effects. Finally, a better understanding of the interactions of amlodipine can help doctors identify potential drug-drug interactions that could be harmful to their patients. By monitoring the interactions of amlodipine with other medications, foods, and herbal supplements, doctors can ensure that their patients are taking the safest and most effective medications for their individual needs.
Amlodipine is a widely used medication for the treatment of high blood pressure, angina, and other cardiovascular conditions. As more research is conducted on amlodipine, a better understanding of its interactions with other medications, foods, and herbal supplements is being revealed. This knowledge can help unlock a new level of cardiovascular care, as doctors can better tailor treatment plans for their patients and identify potential drug-drug interactions that could be harmful. By understanding the interactions of amlodipine, doctors can ensure that their patients are taking the safest and most effective medications for their individual needs.
1.
As EGFR internalization is decreased, BUB1 controls EGFR signaling.
2.
A paper strip test might enable the early detection of cancer.
3.
Breast cancer patients' arms swell less after an effective lymph node transfer.
4.
A First in Total Larynx Transplant; 'Sniffing' Out Lung Cancer; Gen X Cancer Toll
5.
For fit patients with CLL, frontline venetoclax-ibrutinib improves survival.
1.
CENP-H in Cancer: A Key Player in Tumor Progression and a Potential Therapeutic Target
2.
Integrating Immunotherapy and Staging Guidelines in Lung Cancer Treatment
3.
Seeing the Unseen: Examining Chancroid Through Images
4.
Beyond the Standard: Personalized Cancer Vaccines and the Dawn of a New Era in Pediatric Oncology
5.
Unveiling the Mystery of Epstein-Barr Virus: What We Know So Far
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC
2.
Navigating the Complexities of Ph Negative ALL - Part IV
3.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation